| Literature DB >> 23735284 |
Marijke Stevens1, Silke Timmermans, Astrid Bottelbergs, Jerome J A Hendriks, Bert Brône, Myriam Baes, Jan Tytgat.
Abstract
Voltage-gated sodium channels (Navs) are involved in several aspects of the pathogenesis of multiple sclerosis (MS). Within acute MS plaques, they are expressed along demyelinated axons. Studies in experimental autoimmune encephalomyelitis (EAE) demonstrated a neuroprotective effect of non-specific Nav blockers. Further, block of specific Navs involved in MS is suggested to have an advantage over non-specific blockers. We investigated the effects of the synthetic Midi peptide in EAE, as it potently and specifically blocks Nav1.2, Nav1.4 and Nav1.6. Administration of this Midi peptide worsens the clinical disease pattern and Nav1.2 and Nav1.6 expression levels were elevated in brain but not in spinal cord of Midi-treated mice, implicating that Navs play a complex role in the pathogenesis of EAE.Entities:
Keywords: EAE; Experimental autoimmune encephalomyelitis; MOG; MS; Macrophages; Microglia; Multiple sclerosis; Na(v); Neuroprotection; PBS; PHT; TTX; Voltage-gated sodium channel; experimental autoimmune encephalomyelitis; multiple sclerosis; myelin oligodendrocyte glycoprotein; phenytoin; phosphate buffered saline; tetrodotoxin; voltage-gated sodium channel
Mesh:
Substances:
Year: 2013 PMID: 23735284 DOI: 10.1016/j.jneuroim.2013.04.012
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478